Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2014-01-20

Clinical Trial Update: Study of Vilazodone to Treat Social Anxiety Disorder [NA]

View source ↗

Summary

This document reports an update on a clinical trial evaluating vilazodone for social anxiety disorder, with the trial status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Viibryd (vilazodone)

Snippet

Sponsor: The Medical Research Network | Conditions: Social Anxiety Disorder | NA | Status: UNKNOWN